20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €97,660 in 2019
€77,875▲ 22.5%
lowest -€22,185 in 2011
€9,624▲ 327%
peak of €72,425 in 2025
€72,425▲ 15.3%
€307,967▼ 8.4%
peak of 1.1 FTE in 2017
0.3 FTE▲ 50.0%
Board1 name since 2001
1 directorHidden nameVisible after signing in
Documentsfilings and deeds
12-06-202649 days before the deadline
2025abbreviated format
Gross margin from €63,575 to €77,875Result from €2,252 to €9,624Staff from 0.2 FTE to 0.3 FTEEquity from €62,801 to €72,425Cash from €10,235 to €16,681
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 3,986 companies had the same profile as PHARMACIE GOFFIN has now. Each dot stands for 10 companies, two years later.
96.4%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
Micro
20 years or older
solvency 10 to 30%
a profit under 5% of the balance sheet
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,986 companies, not a prediction for PHARMACIE GOFFIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0476440739
Legal-form change · Resignations & appointmentsName hiddenVisible after signing in holds all the shares · Director in office: Hidden nameVisible after signing in (sole director) · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 01-09-2023 · Gazette deed
First establishment
Rue E. Falmagne 7, Profondeville
Incorporation
published on 29-01-2002 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as PHARMACIE GOFFIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €290,000 and €507,000, founded between 1992 and 2007.
The company number of PHARMACIE GOFFIN is 0476.440.739. The VAT number is the same number with BE in front: BE 0476.440.739.
Where is PHARMACIE GOFFIN based?
The registered office is at Rue E. Falmagne 7, 5170 Profondeville.Company details
What does PHARMACIE GOFFIN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE GOFFIN?
PHARMACIE GOFFIN is a private limited company (BV).
When was PHARMACIE GOFFIN founded?
PHARMACIE GOFFIN was founded on 15-01-2002.
Is PHARMACIE GOFFIN still active?
Yes, PHARMACIE GOFFIN is an active enterprise in the KBO register.
How many employees does PHARMACIE GOFFIN have?
PHARMACIE GOFFIN had an average of 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMACIE GOFFIN?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €77,875 and 76 comparable companies (NACE 477). It probably lies between €190,000 and €550,000.
Is PHARMACIE GOFFIN profitable?
In financial year 2025, PHARMACIE GOFFIN made a profit of €9,624.
Where can I find the annual accounts of PHARMACIE GOFFIN?
PHARMACIE GOFFIN filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE GOFFIN due?
PHARMACIE GOFFIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline